BioMarin Pharmaceutical Inc. buy Bank of America Co.
Start price
20.02.25
/
50%
€68.34
Target price
20.02.26
€98.56
Performance (%)
-21.69%
End price
21.02.26
€53.52
Summary
This prediction ended on 21.02.26 with a price of €53.52. The price of BioMarin Pharmaceutical Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -21.69%. Bank_of_America_Co_ has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | 4.333% | 4.333% | -12.188% |
| iShares Core DAX® | 1.762% | 4.305% | 3.356% |
| iShares Nasdaq 100 | 2.295% | 10.662% | 36.809% |
| iShares Nikkei 225® | 5.319% | 8.932% | 49.947% |
| iShares S&P 500 | 1.251% | 5.785% | 25.004% |
Comments by Bank_of_America_Co_ for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target raised by analysts at Bank of America Co. from $99.00 to $103.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Bank_of_America_Co_ for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€52.12
11.03.26
11.03.26
€73.15
11.03.27
11.03.27
-13.60%
27.05.26
27.05.26
Stopped prediction by Bank_of_America_Co_ for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€42.92
19.05.26
19.05.26
€68.72
19.05.27
19.05.27
4.92%
27.05.26
27.05.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€62.80
17.09.24
17.09.24
€103.34
17.09.25
17.09.25
-26.54%
18.09.25
18.09.25